Serum perfluorooctanoate (PFOA) and perfluorooctane sulfonate (PFOS) concentrations and liver function biomarkers in a population with elevated PFOA exposure

Environmental Health Perspectives

Volumn 120, Issue 5, 2012, Pages 655-660

  Gallo, Valentina ^a,b   Leonardi, Giovanni ^a   Genser, Bernd ^c,d   Lopez Espinosa, Maria Jose ^a   Frisbee, Stephanie J ^e   Karlsson, Lee ^a   Ducatman, Alan M ^f   Fletcher, Tony ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^e Center for Cardiovascular and Respiratory Sciences   (United States)

^f WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

C8; Cross sectional study; Liver function biomarkers; PFOA; PFOS; Population based survey

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN GLUCURONIDE; GAMMA GLUTAMYLTRANSFERASE; PERFLUOROOCTANESULFONIC ACID; PERFLUOROOCTANOIC ACID;

ADULT; ARTICLE; CROSS-SECTIONAL STUDY; ENVIRONMENTAL EXPOSURE; FEMALE; HUMAN; LIVER CELL DAMAGE; LIVER FUNCTION; MALE; NORMAL HUMAN; PRIORITY JOURNAL;

ANIMALIA;

EID: 84861074843     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.1104436     Document Type: Article

References (35)

1. Bjork JA, Butenhoff JL, Wallace KB. 2011. Multiplicity of nuclear receptor activation by PFOA and PFOS in primary human and rodent hepatocytes. Toxicology 288:8-17.
2. Clark JM, Brancati FL, Diehl AM. 2003. The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol 98:960-967.
3. Costa G, Sartori S, Consonni D. 2009. Thirty years of medical surveillance in perfluooctanoic acid production workers. J Occup Environ Med 51:364-372.
4. Davis JA, Spaeth JL, Huson C. 1961. A technique for analyzing the effects of group composition. Am Social Rev 26:215-225.
5. D'Hollander W, De Voogt P, De Coen W, Bervoets L. 2010. Perfluorinated substances in human food and other sources of human exposure. Rev Environ Contam Toxicol 208:179-215.
6. Emmett EA, Shofer FS, Zhang H, Freeman D, Desai C, Shar LM. 2006. Community exposure to perfluorooctanoate: relationships between serum concentrations and exposure sources. J Occup Environ Med 48:759-770.
7. Frisbee SJ, Brooks AP, Maher A, Flensborg P, Arnold S, Fletcher T, et al. 2009. The C8 health project: design, methods, and participants. Environ Health Perspect 117:1873-1882.
8. Gallo V, Egger M, McCormack V, Farmer PB, Ioannidis JP, Kirsch-Volders M, et al. 2011. STrengthening the Reporting of OBservational studies in Epidemiology-Molecular Epidemiology (STROBE-ME): an extension of the STROBE statement. PLoS Med 8:e1001117; doi:10.1371/journal.pmed.1001117 [Online 25 October 2011].
9. Goosey E, Harrad S. 2011. Perfluoroalkyl compounds in dust from Asian, Australian, European, and North American homes and UK cars, classrooms, and offices. Environ Int 37:86-92.
10. Ioannou GN, Weiss NS, Boyko EJ, Kahn SE, Lee SP. 2005. Contribution of metabolic factors to alanine aminotransferase activity in persons with other causes of liver disease. Gastroenterology 128:627-635.
11. Kato K, Wong LY, Jia LT, Kuklenyik Z, Calafat AM. 2011. Trends in exposure to polyfluoroalkyl chemicals in the U.S. population: 1999-2008. Environ Sci Technol 45(19):8037-8045.
12. Kim SK, Lee KT, Kang CS, Tao L, Kannan K, Kim KR, et al. 2011. Distribution of perfluorochemicals between sera and milk from the same mothers and implications for prenatal and postnatal exposures. Environ Pollut 159:169-174.
13. Kratz A, Ferraro M, Sluss PM, Lewandrowski KB. 2004. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Laboratory reference values. N Engl J Med 351:1548-1563.
14. Kuklenyik Z, Reich JA, Tully JS, Needham LL, Calafat AM. 2004. Automated solid-phase extraction and measurement of perfluorinated organic acids and amides in human serum and milk. Environ Sci Technol 38:3698-3704.
15. Lau C, Anitole K, Hodes C, Lai D, Pfahles-Hutchens A, Seed J. 2007. Perfluoroalkyl acids: a review of monitoring and toxicological findings. Toxicol Sci 99:366-394.
16. Lee DH, Steffen LM, Jacobs DR. 2004. Association between serum g-glutamyltransferase and dietary factors: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Am J Clin Nutr 79:600-605.
17. Lin CY, Lin LY, Chiang CK, Wang WJ, Su YN, Hung KY. 2010. Investigation of the associations between low-dose serum perfluorinated chemicals and liver enzymes in US adults. Am J Gastroenterol 105:1354-1363.
18. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. 1985. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419.
19. Olsen GW, Zobel LR. 2007. Assessment of lipid, hepatic, and thyroid parameters with serum perfluorooctanoate (PFOA) concentrations in fluorochemical production workers. Int Arch Occup Environ Health 81:231-246.
20. Pyper SR, Viswakarma N, Jia Y, Zhu YJ, Fondell JD, Reddy JK. 2010. PRIC295, a nuclear receptor coactivator, identified from PPARα-interacting cofactor complex. PPAR Res 2010:173907; doi:10.1155/2010/173907 [Online 22 July 2010].
21. Qazi MR, Abedi MR, Nelson BD, DePierre JW, Abedi-Valugerdi M. 2010. Dietary exposure to perfluorooctanoate or perfluorooctane sulfonate induces hypertrophy in centrilobular hepatocytes and alters the hepatic immune status in mice. Int Immunopharmacol 10:1420-1427.
22. Rakhshandehroo M, Hooiveld G, Muller M, Kersten S. 2009. Comparative analysis of gene regulation by the transcription factor PPARα between mouse and human. PLoS One 4:e6796; doi:10.1371/journal.pone.0006796 [Online 27 August 2009].
23. Ren H, Vallanat B, Nelson DM, Yeung LW, Guruge KS, Lam PK, et al. 2009. Evidence for the involvement of xenobiotic-responsive nuclear receptors in transcriptional effects upon perfluoroalkyl acid exposure in diverse species. Reprod Toxicol 27:266-277.
24. Ruhl CE, Everhart JE. 2003. Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States. Gastroenterology 124:71-79.
25. Sakr CJ, Kreckmann KH, Green JW, Gillies PJ, Reynolds JL, Leonard RC. 2007a. Cross-sectional study of lipids and liver enzymes related to a serum biomarker of exposure (ammonium perfluorooctanoate or APFO) as part of a general health survey in a cohort of occupationally exposed workers. J Occup Environ Med 49:1086-1096.
26. Sakr CJ, Leonard RC, Kreckmann KH, Slade MD, Cullen MR. 2007b. Longitudinal study of serum lipids and liver enzymes in workers with occupational exposure to ammonium perfluorooctanoate. J Occup Environ Med 49:872-879.
27. Schumann G, Bonora R, Ceriotti F, Ferard G, Ferrero CA, Franck PF, et al. 2002a. IFCC primary reference procedures for the measurement of catalytic activity concentrations of enzymes at 37 degrees C. International Federation of Clinical Chemistry and Laboratory Medicine. Part 4. Reference procedure for the measurement of catalytic concentration of alanine aminotransferase. Clin Chem Lab Med 40:718-724.
28. Schumann G, Bonora R, Ceriotti F, Ferard G, Ferrero CA, Franck PF, et al. 2002b. IFCC primary reference procedures for the measurement of catalytic activity concentrations of enzymes at 37 degrees C. International Federation of Clinical Chemistry and Laboratory Medicine. Part 6. Reference procedure for the measurement of catalytic concentration of gamma-glutamyltransferase. Clin Chem Lab Med 40:734-738.
29. Sedlak TW, Snyder SH. 2004. Bilirubin benefits: cellular protection by a biliverdin reductase antioxidant cycle. Pediatrics 113:1776-1782.
30. Shin HM, Vieira VM, Ryan PB, Steenland K, Bartell SM. 2011. Retrospective exposure estimation and predicted versus observed serum perfluorooctanoic acid concentrations for participants in the C8 Health Project. Environ Health Perspect 119:1760-1765.
31. Steenland K, Jin C, MacNeil J, Lally C, Ducatman AM, Vieira V, et al. 2009. Predictors of PFOA levels in community surrounding a chemical plant. Environ Health Perspect 117:1083-1088.
32. Tao L, Kannan K, Kajiwara N, Costa MM, Fillmann G, Takahashi S, et al. 2006. Perfluorooctanesulfonate and related fluorochemicals in albatrosses, elephant seals, penguins, and polar skuas from the Southern Ocean. Environ Sci Technol 40:7642-7648.
33. Whitfield JB. 2001. Gamma glutamyl transferase. Crit Rev Clin Lab Sci 38:263-355.
34. Wolf DC, Moore T, Abbott BD, Rosen MB, Das KP, Zehr RD, et al. 2008. Comparative hepatic effects of perfluorooctanoic acid and WY 14,643 in PPAR-a knockout and wild-type mice. Toxicol Pathol 36:632-639.
35. Yang Q, Nagano T, Shah Y, Cheung C, Ito S, Gonzalez FJ. 2008. The PPARα-humanized mouse: a model to investigate species differences in liver toxicity mediated by PPARα. Toxicol Sci 101:132-139.